R1	Has_value Arg1:T3 Arg2:T4	
R2	Has_value Arg1:T1 Arg2:T2	
R3	Has_index Arg1:T7 Arg2:T8	
R4	Has_value Arg1:T5 Arg2:T6	
R5	Has_temporal Arg1:T5 Arg2:T7	
R6	Has_qualifier Arg1:T17 Arg2:T18	
R7	Has_index Arg1:T27 Arg2:T28	
R8	Has_temporal Arg1:T26 Arg2:T27	
*	OR T31 T30
R9	Has_qualifier Arg1:T31 Arg2:T32	
*	OR T37 T38
T1	Person 0 6	Adults
T2	Value 7 20	older than 45
T3	Person 25 33	children
T4	Value 34 55	younger than 18 years
T5	Measurement 57 71	Platelet count
T6	Value 72 92	higher than 30x109/l
T7	Temporal 93 113	at time of screening
T8	Reference_point 104 113	screening
T9	Condition 128 141	secondary ITP
T10	Observation 152 174	family history for ITP
T11	Parsing_Error 143 151	Positive
T12	Condition 199 217	autoimmune disease
T13	Parsing_Error 176 195	Presence or history
T14	Subjective_judgement 218 247	as judged by the investigator
T15	Subjective_judgement 317 346	as judged by the investigator
T16	Subjective_judgement 394 423	as judged by the investigator
T17	Condition 301 316	hepatic disease
T18	Qualifier 292 300	relevant
T19	Parsing_Error 269 288	Presence or history
T20	Parsing_Error 348 367	Presence or history
T21	Condition 371 393	thromboembolic disease
T22	Procedure 439 450	splenectomy
T23	Pregnancy_considerations 452 492	Women who are pregnant or breast feeding
T24	Pregnancy_considerations 494 553	Intention to become pregnant during the course of the study
T25	Pregnancy_considerations 555 598	Lack of safe double contraception (see 7.1)
T26	Procedure 604 615	vaccination
T27	Temporal 616 648	2 weeks prior start of the study
T28	Reference_point 630 648	start of the study
T29	Subjective_judgement 650 809	Drugs with a known impact on the immune system or on platelet function must be recorded and an exclusion of the study should be discussed with the study center
T30	Condition 854 867	alcohol abuse
T31	Condition 846 850;862 867	drug abuse
T32	Qualifier 830 844	non-compliance
T34	Post-eligibility 869 1003	Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia of the study subject
T35	Non-query-able 1005 1119	Participation in another study with investigational drug within the 30 days preceding and during the present study
T36	Non-query-able 1121 1162	Previous enrolment into the current study
T37	Drug 1188 1199	romiplostim
T38	Drug 1203 1214	eltrombopag
T39	Condition 1216 1232	Hypersensitivity
T40	Non-query-able 1317 1409	Enrolment of the investigator, his/her family members, employees and other dependent persons
T41	Non-query-able 1233 1315	to the active substance or to any of the excipients or to E. coli derived proteins
T42	Condition 249 267	Hepatosplenomegaly
